Now showing items 1-2 of 2

    • Zingaro, Ralph A.; Duzkale, Hatice; Freireich, Emil J.; Kantarjian, Hagop; Sotelo-lerma, Merida; Verstovsek, Srdan; Gao, Mingzhang (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2008-07-29)
      The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant ...
    • Carney, Darrell H.; Olszewska-pazdrak, Barbara; Fossum, Theresa W. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-12-18)
      Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.